Five diagnosed prevalent cases will grow to over 714,000. Diagnosed incident cases of B-cell non-Hodgkin’s lymphoma (B-cell ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the ...

Mike Peters, Frontman of The Alarm, dies at 66 after battle with cancer. The legendary rocker, known for fronting Welsh rock ...

Mike Peters, the frontman for the Welsh band The Alarm, has died at the age of 66. Peters’ death was announced by the charity ...

Mike Peters, singer and co-founder of the Welsh rock band the Alarm, has died following a 30-year battle with blood cancer.

Arvinas, Inc. announced promising preclinical results for ARV-393, a targeted protein degrader aimed at treating non-Hodgkin lymphoma, particularly high grade B-cell lymphomas. Data showed that ...

This approval marks the application of the therapy to a wider range of individuals with lymphoma. The therapy is now approved for three indications: relapsed and refractory (R/R) CLL/SLL, R/R marginal ...

BCL2 translocations were lacking in all the cases. Bcl2-positive GCs in PCT are a rare and benign phenomenon, expanding the spectrum of lymphoma-mimicking paediatric RLH.

Epcoritimab is a treatment for diffuse large B-cell lymphoma, a form of Non-Hodgkin lymphoma affecting 2000 Australians annually and characterised by its aggressive growth. Set to be subsidised by ...

Delhi Police apprehended social activist Medha Patkar on Friday due to a defamation case filed by Lieutenant Governor VK Saxena in 2001. This action followed a Delhi court's issuance of a non ...